Insider Buying: Oyster Point Pharma (NASDAQ:OYST) CFO Buys $107,226.00 in Stock

Share on StockTwits

Oyster Point Pharma (NASDAQ:OYST) CFO Daniel Lochner purchased 6,300 shares of the company’s stock in a transaction dated Monday, November 4th. The stock was purchased at an average price of $17.02 per share, for a total transaction of $107,226.00.

Shares of NASDAQ OYST opened at $16.19 on Friday. Oyster Point Pharma has a 52-week low of $15.60 and a 52-week high of $19.01.

About Oyster Point Pharma

Oyster Point Pharma, Inc, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ocular surface diseases in the United States. It is involved in developing OC-01, a nicotinic acetylcholine receptor agonist that is in Phase IIb clinical trial to treat the signs and symptoms of dry eye disease, as well as Phase III clinical trial for the neurotrophic keratitis.

Further Reading: What are convertible shares? 

Receive News & Ratings for Oyster Point Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oyster Point Pharma and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Noble Co. PLC  Expected to Announce Earnings of -$0.43 Per Share
Noble Co. PLC Expected to Announce Earnings of -$0.43 Per Share
CyberMiles Trading Up 3.4% Over Last Week
CyberMiles Trading Up 3.4% Over Last Week
NULS   Trading 3.3% Lower  This Week
NULS Trading 3.3% Lower This Week
DeVault  Price Reaches $0.0002 on Exchanges
DeVault Price Reaches $0.0002 on Exchanges
Bitcoin Interest  Price Hits $0.0386 on Major Exchanges
Bitcoin Interest Price Hits $0.0386 on Major Exchanges
Zacks: SMTC Co.  Given $7.50 Average Price Target by Brokerages
Zacks: SMTC Co. Given $7.50 Average Price Target by Brokerages


© 2006-2019 Ticker Report